What Happened? Shares of healthcare product and device company Abbott Laboratories (NYSE:ABT) fell 3.5% in the afternoon ...

Abbott stock fell as Q3 sales missed estimates and 2025 earnings guidance was narrowed despite solid growth in medical ...

Analysts expect the North Chicago, Illinois-based company to report quarterly earnings at $1.30 per share, up from $1.21 per ...

Healthcare product and device company Abbott Laboratories (NYSE:ABT) will be reporting earnings this Wednesday morning.

Abbott (ABT) reported $11.37 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 6.9%. EPS of $1.30 for the same period compares to $1.21 a year ago. The ...

ABT's Q3 earnings meet expectations as revenues climb 6.9% year over year, driven by double-digit gains in Medical Devices.

Abbott Laboratories (NYSE:ABT) has greatly exceeded the broader S&P 500 index this year, with its stock price increasing by 18% compared to the S&P 500’s 6% rise. This strong performance is due to the ...

Members of Congress have traded $ABT stock 13 times in the past 6 months. Of those trades, 6 have been purchases and 7 have been sales. Here’s a breakdown of recent ...

Abbott Laboratories is set to report Q3 earnings, with EPS expectations of $1.30, reflecting 8.3% YoY growth. Learn more ...

Investors in Abbott Laboratories (Symbol: ABT) saw new options begin trading today, for the September 2026 expiration. One of the key data points that goes into the price an option buyer is willing to ...